239 related articles for article (PubMed ID: 35674639)
41. Utility of the Dermatology Life Quality Index at initiation or switching of biologics in real-life Japanese patients with plaque psoriasis: Results from the ProLOGUE study.
Imafuku S; Kanai Y; Murotani K; Nomura T; Ito K; Ohata C; Yamazaki F; Miyagi T; Takahashi H; Okubo Y; Saeki H; Honma M; Tada Y; Mabuchi T; Higashiyama M; Kobayashi S; Hashimoto Y; Seishima M; Kakuma T
J Dermatol Sci; 2021 Mar; 101(3):185-193. PubMed ID: 33495058
[TBL] [Abstract][Full Text] [Related]
42. Psychosocial burden of patients with atopic dermatitis at two tertiary referral centres in Malaysia.
Tan WF; Voo SYM; Sulaiman N; Robinson S
Med J Malaysia; 2021 Sep; 76(5):643-652. PubMed ID: 34508369
[TBL] [Abstract][Full Text] [Related]
43. Comparison of Patient-Oriented Eczema Measure and Patient-Oriented Scoring Atopic Dermatitis vs Eczema Area and Severity Index and other measures of atopic dermatitis: A validation study.
Silverberg JI; Lei D; Yousaf M; Janmohamed SR; Vakharia PP; Chopra R; Chavda R; Gabriel S; Patel KR; Singam V; Kantor R; Hsu DY
Ann Allergy Asthma Immunol; 2020 Jul; 125(1):78-83. PubMed ID: 32199977
[TBL] [Abstract][Full Text] [Related]
44. Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with Psoriasis.
Davison NJ; Thompson AJ; Turner AJ; Longworth L; McElhone K; Griffiths CEM; Payne K;
Value Health; 2018 Aug; 21(8):1010-1018. PubMed ID: 30098665
[TBL] [Abstract][Full Text] [Related]
45. [Decreased professional performance and quality of life in patients with moderate-to-severe atopic eczema : Results from the German atopic eczema registry TREATgermany].
Haufe E; Abraham S; Heratizadeh A; Harder I; Zink A; Weisshaar E; Kleinheinz A; von Kiedrowski R; Worm M; Bell M; Wollenberg A; Neubert K; Staubach-Renz P; Hilgers M; Bieber T; Fell I; Homey B; Effendy I; Mempel M; Schäkel K; Beissert S; Weidinger S; Werfel T; Schmitt J
Hautarzt; 2018 Oct; 69(10):815-824. PubMed ID: 30191254
[TBL] [Abstract][Full Text] [Related]
46. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.
Cheung PWH; Wong CKH; Cheung JPY
Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342
[TBL] [Abstract][Full Text] [Related]
47. Mapping DLQI on EQ-5D in psoriasis: transformation of skin-specific health-related quality of life into utilities.
Blome C; Beikert FC; Rustenbach SJ; Augustin M
Arch Dermatol Res; 2013 Apr; 305(3):197-204. PubMed ID: 23266843
[TBL] [Abstract][Full Text] [Related]
48. Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey.
Jankowska A; Młyńczak K; Golicki D
Health Qual Life Outcomes; 2021 May; 19(1):138. PubMed ID: 33952271
[TBL] [Abstract][Full Text] [Related]
49. Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2.
Cork MJ; Eckert L; Simpson EL; Armstrong A; Barbarot S; Puig L; Girolomoni G; de Bruin-Weller M; Wollenberg A; Kataoka Y; Remitz A; Beissert S; Mastey V; Ardeleanu M; Chen Z; Gadkari A; Chao J
J Dermatolog Treat; 2020 Sep; 31(6):606-614. PubMed ID: 31179791
[No Abstract] [Full Text] [Related]
50. Health inequities as measured by the EQ-5D-5L during COVID-19: Results from New York in healthy and diseased persons.
Lubetkin EI; Long D; Haagsma JA; Janssen MF; Bonsel GJ
PLoS One; 2022; 17(7):e0272252. PubMed ID: 35901071
[TBL] [Abstract][Full Text] [Related]
51. Comparison between EQ-5D-5L and PROMIS-10 to evaluate health-related quality of life 3 months after stroke: a cross-sectional multicenter study.
DE Graaf JA; Visser-Meily JM; Schepers VP; Baars A; Kappelle LJ; Passier PE; Wermer MJ; DE Wit DC; Post MW
Eur J Phys Rehabil Med; 2021 Jun; 57(3):337-346. PubMed ID: 33448750
[TBL] [Abstract][Full Text] [Related]
52. How Should We Capture Health State Utility in Dementia? Comparisons of DEMQOL-Proxy-U and of Self- and Proxy-Completed EQ-5D-5L.
Martin A; Meads D; Griffiths AW; Surr CA
Value Health; 2019 Dec; 22(12):1417-1426. PubMed ID: 31806199
[TBL] [Abstract][Full Text] [Related]
53. Validation and comparison of 15-D and EQ-5D-5L instruments in a Spanish Parkinson's disease population sample.
García-Gordillo M; del Pozo-Cruz B; Adsuar JC; Sánchez-Martínez FI; Abellán-Perpiñán JM
Qual Life Res; 2014 May; 23(4):1315-26. PubMed ID: 24258254
[TBL] [Abstract][Full Text] [Related]
54. Mapping of the DLQI scores to EQ-5D utility values using ordinal logistic regression.
Ali FM; Kay R; Finlay AY; Piguet V; Kupfer J; Dalgard F; Salek MS
Qual Life Res; 2017 Nov; 26(11):3025-3034. PubMed ID: 28601958
[TBL] [Abstract][Full Text] [Related]
55. Effect on quality of life in patients with pityriasis rosea: is it associated with rash severity?
Chuh AA; Chan HH
Int J Dermatol; 2005 May; 44(5):372-7. PubMed ID: 15869534
[TBL] [Abstract][Full Text] [Related]
56. Health-related quality of life measured using the EQ-5D-5L: South Australian population norms.
McCaffrey N; Kaambwa B; Currow DC; Ratcliffe J
Health Qual Life Outcomes; 2016 Sep; 14(1):133. PubMed ID: 27644755
[TBL] [Abstract][Full Text] [Related]
57. Atopic dermatitis is associated with a decrement in health-related quality of life.
Kiebert G; Sorensen SV; Revicki D; Fagan SC; Doyle JJ; Cohen J; Fivenson D
Int J Dermatol; 2002 Mar; 41(3):151-8. PubMed ID: 12010340
[TBL] [Abstract][Full Text] [Related]
58. Quality of life measurement alteration among Vietnamese: Impact and treatment benefit related to eczema.
Le PH; Vo TQ; Nguyen NH
J Pak Med Assoc; 2019 Jun; 69(Suppl 2)(6):S49-S56. PubMed ID: 31369534
[TBL] [Abstract][Full Text] [Related]
59. Health-related quality of life in adult dermatitis patients stratified by filaggrin genotype.
Heede NG; Thyssen JP; Thuesen BH; Linneberg A; Szecsi PB; Stender S; Johansen JD
Contact Dermatitis; 2017 Mar; 76(3):167-177. PubMed ID: 27995642
[TBL] [Abstract][Full Text] [Related]
60. Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway.
Aas CF; Vold JH; Skurtveit S; Lim AG; Ruths S; Islam K; Askildsen JE; Løberg EM; Fadnes LT; Johansson KA;
Subst Abuse Treat Prev Policy; 2020 Sep; 15(1):68. PubMed ID: 32883319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
